Report Overview
Report Summary
Bisphosphonates are a drugs that treat bone problems, such as thin or fragile bones. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonates market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2027, growing at a CAGR of xx% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Bisphosphonates market based on company, product type, end user and key regions.
This report studies the global market size of Bisphosphonates in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bisphosphonates in these regions.
This research report categorizes the global Bisphosphonates market by top players/brands, region, type and end user. This report also studies the global Bisphosphonates market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Teva
Mylan
Apotex Corp
Pfizer
Sanofi
Roche
Novartis
Eli Lilly
Amgen
Tecoland
Emcure Pharma
Taj Pharmaceuticals
Natco Pharma
Scinopharm Taiwan
Lianyungang Runzhong Pharmaceutical
Hangzhou Longshine Bio-Tech
Market size by Product
Alendronate
Ibandronate
Risedronate
Zoledronic Acid
Market size by End User
Metastatic Bone Cancers
Systemic Metabolic Bone Diseases
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Bisphosphonates market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Bisphosphonates market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bisphosphonates companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bisphosphonates submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Bisphosphonates are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bisphosphonates market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Bisphosphonates Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Bisphosphonates Market Size Growth Rate by Product
1.4.2 Alendronate
1.4.3 Ibandronate
1.4.4 Risedronate
1.4.5 Zoledronic Acid
1.5 Market by End User
1.5.1 Global Bisphosphonates Market Size Growth Rate by End User
1.5.2 Metastatic Bone Cancers
1.5.3 Systemic Metabolic Bone Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bisphosphonates Market Size
2.1.1 Global Bisphosphonates Revenue 2017-2027
2.1.2 Global Bisphosphonates Sales 2017-2027
2.2 Bisphosphonates Growth Rate by Regions
2.2.1 Global Bisphosphonates Sales by Regions
2.2.2 Global Bisphosphonates Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Bisphosphonates Sales by Manufacturers
3.1.1 Bisphosphonates Sales by Manufacturers
3.1.2 Bisphosphonates Sales Market Share by Manufacturers
3.1.3 Global Bisphosphonates Market Concentration Ratio (CR5 and HHI)
3.2 Bisphosphonates Revenue by Manufacturers
3.2.1 Bisphosphonates Revenue by Manufacturers (2017-2020)
3.2.2 Bisphosphonates Revenue Share by Manufacturers (2017-2020)
3.3 Bisphosphonates Price by Manufacturers
3.4 Bisphosphonates Manufacturing Base Distribution, Product Types
3.4.1 Bisphosphonates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bisphosphonates Product Type
3.4.3 Date of International Manufacturers Enter into Bisphosphonates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Bisphosphonates Sales by Product
4.2 Global Bisphosphonates Revenue by Product
4.3 Bisphosphonates Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Bisphosphonates Breakdown Data by End User
6 North America
6.1 North America Bisphosphonates by Countries
6.1.1 North America Bisphosphonates Sales by Countries
6.1.2 North America Bisphosphonates Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Bisphosphonates by Product
6.3 North America Bisphosphonates by End User
7 Europe
7.1 Europe Bisphosphonates by Countries
7.1.1 Europe Bisphosphonates Sales by Countries
7.1.2 Europe Bisphosphonates Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bisphosphonates by Product
7.3 Europe Bisphosphonates by End User
8 Asia Pacific
8.1 Asia Pacific Bisphosphonates by Countries
8.1.1 Asia Pacific Bisphosphonates Sales by Countries
8.1.2 Asia Pacific Bisphosphonates Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Bisphosphonates by Product
8.3 Asia Pacific Bisphosphonates by End User
9 Central & South America
9.1 Central & South America Bisphosphonates by Countries
9.1.1 Central & South America Bisphosphonates Sales by Countries
9.1.2 Central & South America Bisphosphonates Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Bisphosphonates by Product
9.3 Central & South America Bisphosphonates by End User
10 Middle East and Africa
10.1 Middle East and Africa Bisphosphonates by Countries
10.1.1 Middle East and Africa Bisphosphonates Sales by Countries
10.1.2 Middle East and Africa Bisphosphonates Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Bisphosphonates by Product
10.3 Middle East and Africa Bisphosphonates by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Merck Bisphosphonates Products Offered
11.1.5 Merck Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Company Business Overview
11.2.3 Teva Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Teva Bisphosphonates Products Offered
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Company Business Overview
11.3.3 Mylan Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Mylan Bisphosphonates Products Offered
11.3.5 Mylan Recent Development
11.4 Apotex Corp
11.4.1 Apotex Corp Company Details
11.4.2 Company Business Overview
11.4.3 Apotex Corp Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Apotex Corp Bisphosphonates Products Offered
11.4.5 Apotex Corp Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Pfizer Bisphosphonates Products Offered
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Sanofi Bisphosphonates Products Offered
11.6.5 Sanofi Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Company Business Overview
11.7.3 Roche Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Roche Bisphosphonates Products Offered
11.7.5 Roche Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Novartis Bisphosphonates Products Offered
11.8.5 Novartis Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Company Business Overview
11.9.3 Eli Lilly Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Eli Lilly Bisphosphonates Products Offered
11.9.5 Eli Lilly Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Company Business Overview
11.10.3 Amgen Bisphosphonates Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Amgen Bisphosphonates Products Offered
11.10.5 Amgen Recent Development
11.11 Tecoland
11.12 Emcure Pharma
11.13 Taj Pharmaceuticals
11.14 Natco Pharma
11.15 Scinopharm Taiwan
11.16 Lianyungang Runzhong Pharmaceutical
11.17 Hangzhou Longshine Bio-Tech
12 Future Forecast
12.1 Bisphosphonates Market Forecast by Regions
12.1.1 Global Bisphosphonates Sales Forecast by Regions 2021-2027
12.1.2 Global Bisphosphonates Revenue Forecast by Regions 2021-2027
12.2 Bisphosphonates Market Forecast by Product
12.2.1 Global Bisphosphonates Sales Forecast by Product 2021-2027
12.2.2 Global Bisphosphonates Revenue Forecast by Product 2021-2027
12.3 Bisphosphonates Market Forecast by End User
12.4 North America Bisphosphonates Forecast
12.5 Europe Bisphosphonates Forecast
12.6 Asia Pacific Bisphosphonates Forecast
12.7 Central & South America Bisphosphonates Forecast
12.8 Middle East and Africa Bisphosphonates Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bisphosphonates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer